Aminobenzoic acids and derivatives
Aobchem 2 6-Difluoro-3-nitrobenzamide | ≥97% | CAS 124169-54-6 | C7H4F2N2O3 | 250mg
2 6-Difluoro-3-nitrobenzamide | ≥97% | CAS 124169-54-6 | C7H4F2N2O3 | 250mg
Medchemexpress LLC Lomitapide mesylate | 202914-84-9 | MFCD19443682 | 99.6% | C40H41F6N3O5S | 10MG
Lomitapide mesylate is the methanesulfonate salt of lomitapide, a potent inhibitor of microsomal triglyceride-transfer protein (MTP) used as a research reagent. It has a reported in vitro IC50 of 8 nM and is supplied as a high-purity solid suitable for biochemical assays, cell-based studies, and formulation for animal dosing.
- Has potent in vitro activity (IC50 8 nM) against MTP.
- Supplied at high purity (≈99.6%).
- Soluble in DMSO; manufacturer provides recommended in vivo vehicle formulations.
- Available in multiple pack sizes from milligram to gram scale.
- Suitable for biochemical assays, cell-based assays, and in vivo formulation work.
Selleck Chemical LLC Nafamostat mesilate (FUT-175) S1386-10mM/1mL
Nafamostat mesilate is a synthetic serine protease inhibitor used as an anticoagulant during hemodialysis Nafamostat mesylate blocks activation of SARS-CoV-2 and is investigated as a new treatment option for COVID-19 Nafamostat Mesilate attenuates inflammation and apoptosis
TARGETMOL CHEMICALS INC LEUCOMETHYLENE BLUE MESY 25MG
Also available in 5 mg 10 mg 50 mg 100 mg 200 mg 1 mL 10 mM (in DMSO) and bulk. Please contact Fisher for quotes. Leucomethylene blue mesylate (TRx0237 mesylate) is a second-generation tau protein aggregation inhibitor for the treatment of Alzheimer's disease (AD) and frontotemporal dementia. purity: 99%
Selleck Chemical LLC Lenvatinib Mesylate S5240-100mg
Lenvatinib Mesylate is a synthetic orally available tyrosine kinase inhibitor that inhibits vascular endothelial growth factor receptor (VEGFR1-3) fibroblast growth factor receptor (FGFR1-4) platelet-derived growth factor receptor (PDGFR ) stem cell factor receptor (Kit (c-Kit)) and rearranged during transfection (RET (c-RET)) Lenvatinib Mesylate has potential antineoplastic activity
Apexbio Technology LLC Danofloxacin Mesylate 119478-55-6 5g
Danofloxacin Mesylate (119478-55-6) is a small-molecule inhibitor targeting bacterial DNA gyrase and topoisomerase IV It is designed to inhibit these enzymes thereby impeding bacterial DNA replication and transcription Danofloxacin Mesylate exerts its biological activity primarily through inhibition of bacterial DNA gyrase and topoisomerase IV In microbiological assays Danofloxacin demonstrates antibacterial inhibition with a minimum inhibitory concentration (MIC90) of approximately 0 28 M Based on these pharmacological properties Danofloxacin Mesylate holds research potential in veterinary antimicrobial studies investigation of bacterial resistance mechanisms and comparative evaluation of antimicrobial activity
Medchemexpress LLC Purinostat mesylate | 2650188-32-0 | 99.5% | 586.62 | 25 MG
Purinostat mesylate is a selective inhibitor of HDAC. It inhibits class I and class IIb HDACs with IC50s ranging from 0.81 to 11.5 nM. It induces apoptosis and affects the cell cycle of LAMA84 and 188 BL-2 cells, showing potent anti-leukemia effects in vivo. It is used for research on lymphoblastic leukemia.
- Inhibits class I and class IIb HDACs
- Induces apoptosis and affects cell cycle of LAMA84 and 188 BL-2 cells
- Suppresses leukemia progression in vivo
- Demonstrates potent anti-leukemia effects in BCR-ABL(T315I)-induced primary B-ALL mice